Breast Surgery, Plastic & ReconstructiveSurgery, Breast Cancer Genetics/Cancer Risk Assessment
Breast Surgerycombined with Plastic& Reconstructive technology, Breast Cancer Genetics/Cancer Risk Assessment, BreastImplants
Chinese,English, Cantonese
YaleUniversity School of Medicine, Visiting Scholar
HongkongUniversity, Post Doctoral Fellow
SunYat-sen University, MD.PhD
TheWest China of Medical Science
Dr. Yang Mei received her medical degree from Sun Yat-sen Universityand has been in practice for more than 15 years. As a breast surgeon whosefocus is helping people who have had cancer surgery with their recovery, bothin appearance and in function, she specializes in all forms of breast cancerdiagnosis and remove combined with reconstruction, including tissue- andimplant-based techniques. All of these procedures are designed to help cancersurvivors restore their sense of self as they cope with the aftermath of treatment.
Dr. Yang finds her work as a surgeon intellectually stimulating. Sheis especially interested in how she can use complex surgical techniques toachieve the most complete and natural solution to each patient's problems. Sheviews her work as a reconstructive surgeon as an opportunity to help peoplecope with the difficult physical changes that often accompany their cancertreatment. “I am a partner in achieving their goals. I feel personally investedin my patients and their outcomes,” she says.
Dr. Yang is an associate professor of surgery at Guangdong ProvincialPeople’s Hospital. In addition to her work as a surgeon, she has an extensiveresearch background, has published extensively in her field and often makespresentations at national meetings. One of these articles “Microvesicles secreted by macrophages shuttle invasion potentiatingmicroRNAs into breast cancer cells” was cited more than650 times. “Innovation and progress are important to me. Research allows us tofine tune our approach and to figure out the best options in treating ourpatients,” says Dr. Yang.
Best Poster Award of the8th Asia Pacific Symposium on Neural Regeneration & the 5th Pan PacificSymposium on Stem Cells and Cancer Research & the 1st Cross-StraitBiotechnology Forum
(1) Mei Yang*,Yanhui Fan*, Zhi-Yong Wu*,Jin Gu, Zhendong Feng, Qiangzu Zhang,Shunhua Han, Zhonghai Zhang, Xu Li,Yi-Ching Hsueh, Xiaoling Li, Jieqing Li, Meixia Hu, Weiping Li, Hongfei Gao,Ciqiu Yang, Chunming Zhang, Liulu Zhang, Teng Zhu, Minyi Cheng, Fei Ji, JuntaoXu, Hening Cui, Guangming Tan, Michael Q. Zhang, Changhong Liang, Zaiyi Liu,You-Qiang Song, Gang Niu#, Kun Wang#. DAGM: a novel modelling framework toassess the risk of HER2-negative breast cancer based on germline rare codingmutations. Ebiomedicine, 2021. 69.
(2) Mei Yang# *; Zhe Xu#; Qiang-zu Zhang#; Kun Wang#; Xiao-Yang Ji; Juan Xu;Jiang-yu Zhang; Gang Niu*. A breast one-patient panel of heterogeneous genomesreveals genetic alterations driving DCIS into invasive lesions. Future Oncology, 2019, 15(14).
(3) Weidong Ji, Mei Yang,Alexandra Praggastis, Yonghao Li, Huanjiao Jenny Zhou, YunHe，RoxanneGhazvinian, Dylan J. Cincotta, Kevin P. Rice, Wang Min. Carbamoylating activityassociated with the activation of the antitumor agent laromustine inhibitsangiogenesis by inducing ASK1-dependent endothelial cell death. Plos One, 2014,9 (7): e103224.
(4) Bin Y, Mei Yang, Lei Shi, Yandan Yao, Qinqin Jiang,Xuefei Li, Lei-Han Tang, Terence Hwa, Bo-Jian Zheng, Kwok-yung Yuen, David K.Smith, Erwei Song*, Jian-Dong Huang*. Explicit hypoxia targeting with tumorsuppression by creating an “obligate” anaerobic Salmonella Typhimurium strain. Scientific Reports. 2012; 2: 436.
(5) Mei Yang, Jingqi Chen, Fang Su, Bin Yu, Fengxi Su,Ling Lin, Yujie Liu, Jiandong Huang and Erwei Song*. Microvesicles secreted bymacrophages shuttle invasion potentiating microRNAs into breast cancer cells. Molecular Cancer. 2011, 10:117.
(6) Jin, Huan#; Ying, Xiaoling#; Que, Biao; Wang, Xiaoxue; Chao,Yinghui; Zhang, Haiqing; Yuan, Zusen; Qi, Defeng; Lin, Shuibin; Min,Wang; Yang,Mei*; Ji, Weidong*.N-6-methyladenosine modification ofITGA6 mRNA promotes the development and progression of bladder cancer . EBioMedicine, 2019, 47: 195-207.
(7) Mei Yang, Zhe Xu, Qi Wang, An-qin Zhang and Jun Min.A hyposensitive anticancer drug induces higher surface expression and releaseof heat shock proteins in a human hepatocellular carcinoma cell line. MolecularMedicine Reports, 2015, 12(2): 2879-2885.
